Cargando…

Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples

BACKGROUND: For epidemiologic, social and economic reasons, assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prevalence and immunity are important to adapt decisions to current demands. Hence, immunoassays for detection of anti-SARS-CoV-2 antibodies are introduced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haselmann, Verena, Kittel, Maximilian, Gerhards, Catharina, Thiaucourt, Margot, Eichner, Romy, Costina, Victor, Neumaier, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343640/ https://www.ncbi.nlm.nih.gov/pubmed/32652161 http://dx.doi.org/10.1016/j.cca.2020.07.007

Ejemplares similares

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
por: Kittel, Maximilian, et al.
Publicado: (2021)

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
por: Kittel, Maximilian, et al.
Publicado: (2021)

Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines
por: Gerhards, Catharina, et al.
Publicado: (2023)

Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
por: Ast, Volker, et al.
Publicado: (2021)

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
por: Gerhards, Catharina, et al.
Publicado: (2021)

Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome
por: Gerhards, Catharina, et al.
Publicado: (2023)

Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)—Pitfalls of Routine Application
por: Kittel, Maximilian, et al.
Publicado: (2022)

Triptychon: Usability evaluation and implementation of a web-based application for patients’ lab and vital parameters
por: Kittel, Maximilian, et al.
Publicado: (2023)

Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients
por: Gerhards, Catharina, et al.
Publicado: (2023)

Plasma-based S100B testing for management of traumatic brain injury in emergency setting
por: Haselmann, Verena, et al.
Publicado: (2021)

Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms
por: Rotterdam, Jil, et al.
Publicado: (2021)

Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care
por: Haselmann, Verena, et al.
Publicado: (2022)

Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
por: Huseynov, Aydin, et al.
Publicado: (2020)

Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability
por: Findeisen, Peter, et al.
Publicado: (2012)

Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care
por: Hedtke, Maren, et al.
Publicado: (2021)

Validation of a Commercially Available Enzyme ImmunoAssay for the Determination of Oxytocin in Plasma Samples from Seven Domestic Animal Species
por: Bienboire-Frosini, Cecile, et al.
Publicado: (2017)

Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays
por: DomBourian, Melkon G., et al.
Publicado: (2020)

Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety
por: Liew, Oi Wah, et al.
Publicado: (2022)

Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020)

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
por: Weidner, Lisa, et al.
Publicado: (2020)

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
por: Ige, Fehintola, et al.
Publicado: (2021)

Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
por: Nilles, Eric J., et al.
Publicado: (2020)

Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
por: Rotterdam, Jil, et al.
Publicado: (2022)

Coupling size exclusion chromatography to ultracentrifugation improves detection of exosomal proteins from human plasma by LC-MS
por: Alameldin, Sara, et al.
Publicado: (2021)

Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies
por: Lokida, Dewi, et al.
Publicado: (2022)

A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2020)

Evaluation of the Elecsys syphilis immunoassay for routine screening of serum samples in China
por: Tao, Chuanmin, et al.
Publicado: (2017)

Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection
por: Serrano, Maria Martínez, et al.
Publicado: (2020)

Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays
por: Wellinghausen, Nele, et al.
Publicado: (2020)

Evaluation of 5 Commercially Available Zika Virus Immunoassays
por: Safronetz, David, et al.
Publicado: (2017)

SARS-CoV-2 antibody testing—questions to be asked
por: Özçürümez, Mustafa K., et al.
Publicado: (2020)

Serological diagnosis of Leptospirosis in bovine serum samples using a microsphere immunoassay
por: Wynwood, S. J., et al.
Publicado: (2016)

Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays
por: Santano, Rebeca, et al.
Publicado: (2021)

Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples
por: Jargalsaikhan, Ganbolor, et al.
Publicado: (2020)

Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma
por: Egger, Margot, et al.
Publicado: (2020)

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
por: Zava, Theodore T, et al.
Publicado: (2020)

Sensitivity and specificity of a lateral flow immunoassay (LFI) in serum samples for diagnosis of melioidosis
por: Wongsuvan, Gumphol, et al.
Publicado: (2018)

Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection
por: Chua, Kyra Y.L., et al.
Publicado: (2020)

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
por: Šimánek, Václav, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dfbu227ukcphh0q7q4sssm8sln